Spyre Therapeutics SYRE
NASDAQ SYRE
$93.19 +3.26 (+3.63%)
At close: Oct 2, 2026 · 4:00 PM EDT

Spyre Therapeutics (SYRE) Change in Intangibles (2025 - 2026)

Updated

Spyre Therapeutics (SYRE) posted Change in Intangibles of $40 million for Q2 2026, up 471.4% from $7 million a year earlier and up 33.3% from the prior quarter.

Analysis

Spyre Therapeutics (SYRE) Change in Intangibles (2025 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Change in Intangibles at Spyre Therapeutics was $70 million, up 900.0% year-over-year; for FY2025, it came in at $7 million.

  • In prior years, Spyre Therapeutics' Change in Intangibles was $15 million in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Intangibless (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 3.28 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -437.00 Mn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -2.34 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Spyre Therapeutics 8.21 Bn 8.21 Bn - 40.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 40.00 Mn
Mar 31, 2026 30.00 Mn
Jun 30, 2025 7.00 Mn
API Access

Spyre Therapeutics Change in Intangibles API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-intangibles&ticker=SYRE&period=max&api_key=YOUR_API_KEY